Trial · NCT02242643
Adverse events94
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 94
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper respiratory tract infection | Infections and infestations | FluLaval™ Quadrivalent Group | 111 | 1,207 | |
| other | Upper respiratory tract infection | Infections and infestations | Fluzone® Quadrivalent Group | 102 | 1,217 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | FluLaval™ Quadrivalent Group | 70 | 1,207 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Fluzone® Quadrivalent Group | 77 | 1,217 | |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | FluLaval™ Quadrivalent Group | 59 | 1,207 | |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | Fluzone® Quadrivalent Group | 76 | 1,217 | |
| other | Nasopharyngitis | Infections and infestations | FluLaval™ Quadrivalent Group | 66 | 1,207 | |
| other | Nasopharyngitis | Infections and infestations | Fluzone® Quadrivalent Group | 54 | 1,217 | |
| other | Diarrhoea | Gastrointestinal disorders | FluLaval™ Quadrivalent Group | 66 | 1,207 | |
| other | Diarrhoea | Gastrointestinal disorders | Fluzone® Quadrivalent Group | 53 | 1,217 | |
| other | Otitis media | Infections and infestations | FluLaval™ Quadrivalent Group | 61 | 1,207 | |
| other | Otitis media | Infections and infestations | Fluzone® Quadrivalent Group | 49 | 1,217 | |
| other | Drowsiness | General disorders | FluLaval™ Quadrivalent Group | 471 | 1,159 | |
| other | Drowsiness | General disorders | Fluzone® Quadrivalent Group | 471 | 1,152 | |
| other | Fever | General disorders | FluLaval™ Quadrivalent Group | 183 | 1,159 | |
| other | Fever | General disorders | Fluzone® Quadrivalent Group | 178 | 1,152 | |
| other | Irritability/Fussiness | General disorders | FluLaval™ Quadrivalent Group | 630 | 1,159 | |
| other | Irritability/Fussiness | General disorders | Fluzone® Quadrivalent Group | 582 | 1,152 | |
| other | Loss of Appetite | General disorders | FluLaval™ Quadrivalent Group | 391 | 1,159 | |
| other | Loss of Appetite | General disorders | Fluzone® Quadrivalent Group | 385 | 1,152 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02242643/events